F#ck The Stigma INC 501(c)(3)’s Post

Veterans service organizations are calling on Congress to prioritize psychedelic therapy and medical marijuana for veterans' mental health care. During recent hearings, groups like the Iraq and Afghanistan Veterans of America and Veterans of Foreign Wars emphasized the readiness of veterans to explore alternative treatments, citing positive outcomes from research on medical cannabis. They urged policymakers to address practical challenges in implementing and scaling psychedelic-assisted therapy, highlighting the potential benefits for veterans struggling with PTSD and depression. This advocacy underscores the growing recognition of alternative therapies' role in addressing veterans' mental health needs. #veterans #mentalhealth #psychedelictherapy #medicalmarijuana #advocacy https://lnkd.in/dHhuPCwQ?

Psychedelics Inching Forward in the news! 🌿 The House has passed veterans-focused marijuana and psychedelics amendments, allowing VA doctors to recommend these substances for therapeutic use. This move signals a positive shift towards more open policies and better treatment options for our veterans, particularly those battling PTSD. Read more about this significant step and its implications here: https://lnkd.in/engskDeU #Psychedelics #Marijuana #Veterans #Healthcare #PolicyUpdate

Today is Drug Enforcement Administration National Prescription Drug Take Back Day, a day where individuals are encouraged to safely dispose of unused or expired prescription medications.   As a non-profit OTC naloxone provider, Harm Reduction Therapeutics Inc., understands the critical importance of removing unused prescription drugs from our communities.   Bring your unused or expired prescription medications to designated drop-off locations, where they'll be safely disposed of.   Click on the link below to find a Collection Site near you:   https://lnkd.in/d8f_JyUV   Together, we can prevent substance misuse and protect our loved ones. Your participation can save lives! #DrugTakeBackDay #OpioidPrevention #SaveLives

📢 Check out the latest blog post on Intractable Epilepsy! This time, we dive into the adverse effects of Epidiolex, an isolated cannabis based drug licensed to be prescribed in the U.K. for Dravets syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex. 🧪 It's important for everyone to be aware of the potential risks of medicines. The link below will take you directly to the blog post, where you'll find in-depth analysis and insights. Remember, knowledge is power! Stay informed and share this important information with your loved ones who may be affected by intractable epilepsy. 💜 #IntractableEpilepsy #Epidiolex #AdverseEffects #FDA #EpilepsyAwareness https://lnkd.in/eMPqGQcd

The news media, the medical community, schools, parents, teens, and young adults are all acknowledging the heightened risks of today's marijuana products to young people. NASEM Health and Medicine Division is calling for tighter regulations. Now is the time for states to enact the regulatory provisions aimed at protecting young people that Partnership to End Addiction recommended in our report: drugfree.org/mjpolicy

In a recent joint committee meeting of the U.S. House and Senate, veterans service organizations (VSOs) passionately advocated for exploring the potential benefits of psychedelic-assisted therapy and medical marijuana. Notable organizations like the Iraq and Afghanistan Veterans of America (IAVA), Veterans of Foreign Wars of the United States (VFW), Disabled American Veterans, and the Wounded Warrior Project underscored the urgent need for congressional action. IAVA emphasized that veterans are increasingly open to alternative therapies, with a significant majority expressing support for expanded access to psychedelic treatment options within the VA. VFW echoed these sentiments, urging policymakers to advance medical cannabis and explore alternative therapies for veterans' mental health issues. Furthermore, they highlighted ongoing VA research into MDMA and psilocybin for PTSD and depression. While VSOs welcomed VA's steps toward psychedelic research, they raised concerns about capacity challenges and the need for clear implementation strategies. Retired Lt. Gen. Michael S. Linnington from the Wounded Warrior Project emphasized the importance of scaling treatment to meet the needs of veterans and providing tailored follow-up care. Additionally, VSOs stressed the necessity of differentiating between various psychedelic therapies and ensuring access to accurate information. They called for collaboration among stakeholders to address the complexities of psychedelic-assisted therapy effectively. Moving forward, VSOs will continue to advocate for VA research into medical cannabis and alternative therapies, prioritizing veterans' well-being. Their efforts underscore the critical role of veterans in advancing drug policy reform and expanding access to innovative treatments. As the conversation around psychedelic-assisted therapy evolves, VSOs remain committed to supporting comprehensive and evidence-based approaches to veteran health care. #VeteransHealth #PsychedelicTherapy #VeteransSupport #PTSDTreatment #MentalHealthCare #VeteransAdvocacy #VAResearch #DrugPolicy #VAHealthcare #PolicyReform https://shorturl.at/eflmo

This week, the Missouri Department of Health and Senior Services (DHSS) transferred $10,918,344 in funds generated by Missouri’s adult use marijuana program to agencies as outlined in Article XIV, Section 2, of the Missouri Constitution. Recipient agencies of adult use program funds include the following: Missouri Veterans Commission ($3,639,448): for use exclusively for health care and other services for military veterans and their dependent families; Missouri State Public Defender ($3,639,448): to be used only for legal assistance for low-income Missourians; DHSS ($3,639,448): to operate a grant program for subrecipients to increase access to evidence-based, low-barrier drug addiction treatment prioritizing medically […] https://lnkd.in/gergSMZg

Lawmakers in Missouri’s House of Representatives have given preliminary #approval to a budget #bill that would spend $10 million from #state #opioid settlement #funds on #research #grants to #study the use of #psilocybin to treat opioid use #disorder. A Stanford University study published earlier this year found that #military combat #veterans with traumatic brain injury (#tbi) saw “dramatic” and “life-changing” improvements in their #symptoms and #cognitive functioning immediately after receiving treatment with #ibogaine. In response to the increased demand for #research, DEA has proposed a dramatic escalation in the production quota for ibogaine and other #psychedelic #compounds in 2024. In the coming decades, Missouri is set to receive hundreds of millions of dollars in opioid-related settlement funds. Psychedelic #medicine proponents have been working to encourage states to use those #millions to fund further research into #ibogaine and other #entheogens. https://lnkd.in/eTY3aWNi

Encouraging news. Hopefully this represents a real trend. While it's too early to know what factors might be responsible for driving down OD deaths, one PWUD interviewed for this story credited Narcan and testing strips as saving lives. I encourage *anyone* who uses illicit drugs--not just opioids--to carry Narcan and test their supply. Drugs like cocaine may be fentanyl-adulterated, too. #harmreduction #narcan #narcansaveslives

The opioid epidemic has cast a long shadow across our communities, and at the heart of this crisis lies a potent substance: Fentanyl. Our latest blog post sheds light on the harrowing reality of fentanyl abuse and its impact on society. We explore the alarming potency and devastating consequences of this synthetic opioid that is up to 100 times stronger than morphine. #FentanylAwareness #OpioidEpidemic #fentanyloverdose #fentanyltest #fentanylepidemic #fentanyl Origin, Inc. (Origin Diagnostics) https://lnkd.in/gzB2xXgq